Efficacy of triple therapy with thymalfasin, peginterferon α-2a, and ribavirin for the treatment of hispanic chronic HCV nonresponders

Efficacy of triple therapy with thymalfasin, peginterferon α-2a, and ribavirin for the treatment of hispanic chronic HCV nonresponders

Background/Aims: Thymalfasin has shown efficacy in the treatment of chronic HCV infection. The aim of this study was to evaluate the efficacy and tolerability of triple therapy with thymalfasin, peginterferon α-2a (PEG-IFN α-2a), and ribavirin in Hispanic patients with chronic viral hepatitis C who...

Full description

Bibliographic Details
Main Authors: Jorge L. Poo, Francisco Sánchez Ávila, David Kershenobich, Xochitl García Samper, Rocío Torres-Ibarra, Julieta Góngora, Carlos Cano, Miguel Parada, Misael Uribe
Format: Article
Language:English
Published: Elsevier 2008-10-01
Series:Annals of Hepatology
Subjects:
Chronic hepatitis C
thymosin alpha 1
thymalfasin
pegylated interferon
peginterferon α-2a
ribavirin
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119318393

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119318393

Similar Items